Sheela Foam Q2 FY27 consolidated revenue Rs 1,045.00 cr, PAT Rs 46.00 cr
For Q2 FY27, Sheela Foam’s consolidated revenue from operations was Rs 1,045.00 cr and PAT Rs 46.00 cr, up from Rs 875.00 cr and Rs 10.00 cr in Q2 FY26.
Key takeaways
- Revenue from operations Rs 1,045.00 cr in Q2-FY27 vs Rs 875.00 cr in Q2-FY26
- Reported EBITDA Rs 83.00 cr in Q2-FY27 vs Rs 87.00 cr in Q2-FY26
- PBT Rs 53.00 cr in Q2-FY27 vs Rs 20.00 cr in Q2-FY26
- PAT Rs 46.00 cr in Q2-FY27 vs Rs 10.00 cr in Q2-FY26
- Diluted EPS (INR) 4.2 in Q2-FY27 vs 0.9 in Q2-FY26
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 1,045.00 cr | Rs 875.00 cr | +19.4% |
| PAT | Rs 46.00 cr | Rs 10.00 cr | +360.0% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 4.40% of revenue, up 325 bps from 1.14%.
- Total expenses rose 22.1% while revenue rose 19.4%.
• Basis: Consolidated income statement, Q2-FY27 vs Q2-FY26 (statement of financial results in the investor presentation)
• Revenue from operations: Rs 1,045.00 cr (Q2-FY27) vs Rs 875.00 cr (Q2-FY26)
• Operating expenses: Rs 962.00 cr (Q2-FY27) vs Rs 788.00 cr (Q2-FY26)
• Reported EBITDA: Rs 83.00 cr (Q2-FY27) vs Rs 87.00 cr (Q2-FY26)
• Reported EBITDA Margin (%): 8.0% (Q2-FY27) vs 10.0% (Q2-FY26)
• Other income: Rs 22.00 cr (Q2-FY27) vs Rs 11.00 cr (Q2-FY26)
• Depreciation: Rs 34.00 cr (Q2-FY27) vs Rs 50.00 cr (Q2-FY26)
• Finance cost: Rs 17.00 cr (Q2-FY27) vs Rs 28.00 cr (Q2-FY26)
• PBT: Rs 53.00 cr (Q2-FY27) vs Rs 20.00 cr (Q2-FY26)
• Exceptional item: Rs - (Q2-FY27) vs Rs 8.00 cr (Q2-FY26)
• Tax: Rs 12.00 cr (Q2-FY27) vs Rs 5.00 cr (Q2-FY26)
• Share in profit/(loss) of Joint venture: Rs 5.00 cr (Q2-FY27) vs Rs 2.00 cr (Q2-FY26)
• PAT: Rs 46.00 cr (Q2-FY27) vs Rs 10.00 cr (Q2-FY26)
• PAT Margin (%): 4.4% (Q2-FY27) vs 1.1% (Q2-FY26)
• Other comprehensive income: Rs 9.00 cr (Q2-FY27) vs Rs 18.00 cr (Q2-FY26)
• Total comprehensive income: Rs 55.00 cr (Q2-FY27) vs Rs 28.00 cr (Q2-FY26)
• Diluted EPS (INR): 4.2 (Q2-FY27) vs 0.9 (Q2-FY26)
In the consolidated statement of financial results for the quarter ended Q2-FY27, Sheela Foam reported revenue from operations of Rs 1,045.00 cr, higher than the Rs 875.00 cr recorded in the corresponding quarter Q2-FY26. Operating expenses also increased to Rs 962.00 cr from Rs 788.00 cr over the same period. Reported EBITDA was Rs 83.00 cr in Q2-FY27 compared with Rs 87.00 cr in Q2-FY26, and the reported EBITDA Margin (%) moved from 10.0% in Q2-FY26 to 8.0% in Q2-FY27, as per the consolidated income statement in the investor presentation.
Below EBITDA, other income rose to Rs 22.00 cr in Q2-FY27 from Rs 11.00 cr a year earlier. Depreciation declined to Rs 34.00 cr from Rs 50.00 cr, and finance cost reduced to Rs 17.00 cr from Rs 28.00 cr between Q2-FY26 and Q2-FY27. Profit before tax (PBT) increased to Rs 53.00 cr in Q2-FY27 from Rs 20.00 cr in Q2-FY26. The exceptional item line was shown as Rs - in Q2-FY27 versus Rs 8.00 cr in Q2-FY26. Tax expense was Rs 12.00 cr in Q2-FY27 compared with Rs 5.00 cr in Q2-FY26, while share in profit/(loss) of joint venture rose to Rs 5.00 cr from Rs 2.00 cr.
Profit after tax (PAT) for Q2-FY27 was Rs 46.00 cr, up from Rs 10.00 cr in Q2-FY26, and PAT Margin (%) was 4.4% versus 1.1% a year earlier. Other comprehensive income stood at Rs 9.00 cr in Q2-FY27 against Rs 18.00 cr in Q2-FY26, taking total comprehensive income to Rs 55.00 cr in Q2-FY27 compared with Rs 28.00 cr in Q2-FY26. Diluted EPS (INR) for the quarter was 4.2, compared with 0.9 in the corresponding quarter of the previous year, as reported in the consolidated income statement.
Track Sheela Foam Ltd
Cruxal reads every Sheela Foam Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.